As injectable medications, some people may experience skin reactions at the injection site, though these are usually mild and go away on their own
Comparing the other GLP-1 RAs to nonusers, however, revealed a very minimal increased risk overall: HR 1.07
CJC-1295 pharmacology: Human studies confirmed dose-dependent IGF-1 increases of 35-120%, sustained over the dosing period (Teichman et al., 2006)
This is the single highest impact change, since a stomach that empties more slowly reads the amount that felt normal before treatment as overeating, so cutting portions substantially and adding a small snack later if genuinely hungry keeps the stomach from becoming overfull, and frequent small meals generally sit better than two or three large ones
The treatment group had mild effect on decreased sensitisations and less severe asthma, 6 months after discontinuation of the supplementation (113)
If you wear contact lenses, wear your glasses instead